Targeting the stage-specific embryonic antigen (SSEA)-0 tumor neoantigen
{{output}}
Recognition of abnormal glycosylation in virtually any cancer type has raised a great interest in the glycan-based tumor biomarkers. Our team explored carbohydrate microarrays as a broad-spectrum immunoassay to probe the immunologically potent tumor glycan tar... ...